Having joined in 2002, Anthony is one of the longest-serving members of our team and is currently a Client Partner with the company. He earned his PhD in pharmacology and biochemistry before becoming a postdoctoral researcher at the University of Southampton. From there, he entered the world of healthcare market research, working for the likes of MMR International, IMS Health (now IQVIA) and NOP World (now GfK). He has consulted across the therapeutic spectrum and throughout the product life cycle; however, at Prescient he particularly enjoys developing clinical strategies in oncology, infectious diseases and cardiometabolic diseases.
Featured
The Living Launch Plan: Keeping Pharma Launch Strategy Aligned
Discover how a living launch plan helps pharmaceutical teams adapt to evolving evidence, competitive dynamics, and changing market conditions.
News and insights
Featured
The New Drivers of Pharma Launch Uptake
Learn why precision in launch strategy is becoming essential for improving pharmaceutical launch uptake and commercial performance.
One-Size-Fits-All Launches Are Over
Read the article to discover why modern pharma launches require a precision approach, helping teams prioritize Must-Win Moments, reduce risk, and improve launch success.
ONWARD: Driving Equitable Access and System Readiness in Cancer Care
This Dolon Institute paper highlights six interconnected barriers affecting timely access to oncology innovation, drawing on examples from healthcare systems around the world.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
